Please use this identifier to cite or link to this item:
|Title:||Antigenic and genomic relation between human influenza viruses that circulated in Argentina in the period 1995-1999 and the corresponding vaccine components||Authors:||Pontoriero, Andrea
Savy, Vilma L.
|Keywords:||Virus de la Influenza A;Vacunas contra la Influenza;Pruebas de Inhibición de Hemaglutinación;Filogenia||Issue Date:||Oct-2003||Journal:||Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology||Abstract:||
Background: The analysis of epidemic influenza virus has been focused on antigenic and genomic characterization of the hemagglutinin (HA) glycoprotein in order to detect new variants for the recommendation of the vaccine strains in each season. Since October 1998, WHO organized a second meeting to evaluate the vaccine formula for the southern hemisphere.
Objectives: (a) Present the antigenic and genomic characterization of influenza strains obtained from the Argentina surveillance network, (b) compare between strains collected in Argentina and other countries with the vaccine formula strains used in each season.
Study design: Influenza strains were collected during a 5-year period (1995 /1999). Initially, laboratory diagnosis was done by immunofluorescence (IF) assay on clinical samples, followed by viral isolation in Madin /Darby canine kidney (MDCK) cells. The isolates were characterized antigenically by hemagglutination-inhibition (HI) assay with post-infection ferret antisera. The genomic characterization consisted on RT-PCR followed by sequencing of the HA1 portion of the HA gene. The comparison between reference and circulating strains was analyzed by the construction of phylogenetic trees.
Results: The H3N2 circulating strains matched the corresponding vaccine component only in 1999, the first year when a vaccine recommended specifically for the southern hemisphere was used. Besides, H1N1 circulating strains matched the corresponding vaccine component only in 1998. Regarding to influenza B, only in 1995, the circulating strains showed no match to the B vaccine component.
Conclusions: The results showed the usefulness of an intensified influenza laboratory surveillance to access the correct vaccine and the importance of having the necessary tools to characterize the circulating strains. # 2003 Elsevier Science B.V. All rights reserved
Fil: Pontoriero, Andrea. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento Virología; Argentina.
Fil: Baumeister, Elsa. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento Virología; Argentina.
Fil: Campos, Ana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento Virología; Argentina.
Fil: Savy, Vilma L. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento Virología; Argentina.
Fil: Lin, Yi. National Institute for Medical Research. Virology Division; Londres, Inglaterra.
Fil: Hay, Alan. National Institute for Medical Research. Virology Division; Londres, Inglaterra.
|Appears in Collections:||Publicaciones INEI|
Show full item record
checked on May 20, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.